SCHEMBL8675465

SCHEMBL8675465

COc1ccc(-c2ccc(-c3ccc(OC)cc3)c(-c3ccc(O)cc3)n2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.59
KMT2A Q03164 5/20 0.59
MEN1 O00255 3/20 0.59
NPC1 O15118 3/20 0.59
ESR2 Q92731 1/20 0.56
KDM4E B2RXH2 2/20 0.54
POLB P06746 1/20 0.54
ATM Q13315 1/20 0.54
ALK Q9UM73 1/20 0.53
NOX1 Q9Y5S8 1/20 0.52
CYP1A1 P04798 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2E1 P05181 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C8 P10632 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2A6 P11509 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP4B1 P13584 1/20 0.50
CYP2B6 P20813 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8680387 0.94 MAPT (0.56) MAPTKMT2AMEN1NPC1ESR2
SCHEMBL8677193 0.93 MAPT (0.52) MAPTKMT2AMEN1NPC1ESR2
SCHEMBL10976797 0.87 KDM4E (0.58) MAPTKMT2ANPC1KDM4ETP53
SCHEMBL10991494 0.87 KDM4E (0.58) MAPTKMT2ANPC1KDM4ETP53
SCHEMBL10992874 0.86 ACHE (0.49) MAPTKMT2AMEN1NPC1KDM4E
SCHEMBL5359428 0.86 NPC1 (0.59) MAPTKMT2AMEN1NPC1KDM4E
SCHEMBL10988231 0.86 KMT2A (0.48) MAPTKMT2AMEN1NPC1KDM4E
SCHEMBL10993183 0.86 SQOR (0.53) MAPTKMT2AMEN1NPC1KDM4E
SCHEMBL10988161 0.86 PIK3CA (0.50) MAPTKMT2AMEN1NPC1KDM4E
SCHEMBL8678271 0.84 ESR2 (0.56) MAPTKMT2AMEN1NPC1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750708-A Pyridine compounds intermediates processes compositions and methods ELI LILLY AND COMPANY (US) 1998-05-12 US disclosed
US-5672609-A POSTMENOPAUSAL SYNDROME; ANTILIPEMIC AND -CARCINOGENIC AGENTS; OSTEOPOROSIS; CARDIOTONIC AGENTS; RESTENOSIS; SIDE EFFECT REDUCTION COMPARED TO ESTROGEN ELI LILLY AND COMPANY (US) 1997-09-30 US disclosed
WO-1997004778-A1 PYRIDINE COMPOUNDS, INTERMEDIATES, PROCESSES, COMPOSITIONS, AND METHODS ELI LILLY AND COMPANY (US) 1997-02-13 WO disclosed